EUVIMEDOpdag EUVIMED
Open access · CC BY-NC-ND 4.0

Continuous multi‐column capture of monoclonal antibodies with convective diffusive membrane adsorbers

Fabian Schmitz, Elias Knöchelmann, Thomas Kruse, Mirjana Minceva iD, Markus Kampmann

Biotechnology and Bioengineering · 2024-06 · 121 (6) · 1859-1875

DOI: 10.1002/bit.28695 ↗

At a glance

Journal article in Biotechnology and Bioengineering, 2024-06. Written by Fabian Schmitz and 4 co-authors. Institution: Biothermodynamics, TUM School of Life Sciences, Technical University of Munich, Freising, Germany. Major MEDLINE topics: Antibodies, Monoclonal, Membranes, Artificial, Cricetulus. Cited 10 times so far (Crossref); 61 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Downstream processing is the bottleneck in the continuous manufacturing of monoclonal antibodies (mAbs). To overcome throughput limitations, two different continuous processes with a novel convective diffusive protein A membrane adsorber (MA) were investigated: the rapid cycling parallel multi‐column chromatography (RC‐PMCC) process and the rapid cycling simulated moving bed (RC‐BioSMB) process. First, breakthrough curve experiments were performed to investigate the influence of the flow rate on the mAb dynamic binding capacity and to calculate the duration of the loading steps. In addition, customized control software was developed for an automated MA exchange in case of pressure increase due to membrane fouling to enable robust, uninterrupted, and continuous processing. Both processes were performed for 4 days with 0.61 g L −1 mAb‐containing filtrate and process performance, product purity, productivity, and buffer consumption were compared. The mAb was recovered with a yield of approximately 90% and productivities of 1010 g L −1 d −1 (RC‐PMCC) and 574 g L −1 d −1 (RC‐BioSMB). At the same time, high removal of process‐related impurities was achieved with both processes, whereas the buffer consumption was lower for the RC‐BioSMB process. Finally, the attainable productivity for perfusion bioreactors of different sizes with suitable MA sizes was calculated to demonstrate the potential to operate both processes on a manufacturing scale with bioreactor volumes of up to 2000 L.

Subjects

MeSH terms (MEDLINE)

Antibodies, MonoclonalMembranes, ArtificialCricetulusAdsorptionCHO CellsBioreactorsStaphylococcal Protein AAnimalsChromatography, Affinity

Author keywords

affinity chromatographycontinuous downstream processingmembrane chromatographymonoclonal antibody purificationmulti‐column chromatography

Substances

Antibodies, MonoclonalMembranes, ArtificialStaphylococcal Protein A

Authors and institutions

  • Biothermodynamics, TUM School of Life Sciences, Technical University of Munich, Freising, Germany.
  • Corporate Research, Sartorius Stedim Biotech GmbH, Göttingen, Germany.

ORCID profiles: Mirjana Minceva

Cite

APA

Schmitz, F., Knöchelmann, E., Kruse, T., Minceva, M., & Kampmann, M. (2024). Continuous multi‐column capture of monoclonal antibodies with convective diffusive membrane adsorbers. Biotechnology and Bioengineering. https://doi.org/10.1002/bit.28695

Vancouver

Schmitz F, Knöchelmann E, Kruse T, Minceva M, Kampmann M. Continuous multi‐column capture of monoclonal antibodies with convective diffusive membrane adsorbers. Biotechnology and Bioengineering. 2024. doi:10.1002/bit.28695

BibTeX
@article{Schmitz2024,
  author = {Schmitz, Fabian and Knöchelmann, Elias and Kruse, Thomas and Minceva, Mirjana and Kampmann, Markus},
  title = {Continuous multi‐column capture of monoclonal antibodies with convective diffusive membrane adsorbers},
  journal = {Biotechnology and Bioengineering},
  year = {2024},
  doi = {10.1002/bit.28695}
}
Start for free →